Real‐world experience of adjuvant immunotherapy for stages III–IV melanoma: A monocentric observational study

Real‐world experience of adjuvant immunotherapy for stages III–IV melanoma: A monocentric observational study

Abstract Background Adjuvant immunotherapy (AIO) improved recurrence‐free survival (RFS) in patients with resected stages III–IV melanoma. Real‐world data, especially in elderly patients, as well as optimal management of patients who relpases, are still limited. Objectives To evaluate real‐world out...

Full description

Saved in:
Bibliographic Details
Main Authors: Manon Blaise, Eric Fontas, Barbara Seitz‐Polski, Laura Troin, Alexandra Picard, Perrine Rousset, Elodie Long‐Mira, Micheline Razzouk‐Cadet, Madleen Chassang, Thierry Passeron, Henri Montaudié
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:JEADV Clinical Practice
Subjects:
adjuvant treatment
elderly
immunotherapy
melanoma
real‐world
Online Access:https://doi.org/10.1002/jvc2.571
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jvc2.571

Similar Items